MNKD
MannKind Corporation
NASDAQ · Healthcare · Biotechnology · US
$4.06
+2.53%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 170.96x
- P/E 2028E
- 147.64x
- P/S forward
- 2.55x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -19.43x
- Price / sales
- 3.32x
- Price / cash flow
- -153.82x
Enterprise value
- Enterprise value
- $1.5B
- EV / sales
- 3.87x
- EV / EBITDA
- 49.61x
- EV / EBIT
- 196.70x
- Market cap
- $1.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026